by Jennifer Lines, PharmD Candidate, PCCA Clinical Services Intern, and Catherine Henderson, PharmD, PCCA Clinical Compounding Pharmacist Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized metabolic health and weight management, leading to a host of new weight loss wonder drugs
Abstract The objective of this study was to compare the effectiveness of subcutaneous (SC) and sublingual (SL) formulations of apomorphine for the treatment of motor fluctuations in Parkinsons disease using a pharmacokinetics (PK)/pharmacodynamics (PD) modeling approach
For more information, reach out to the Fagron Academy team at [email protected]
Still, just a small percentage of people have used GLP-1 agonists and many do not know much about them
When a vial is partially used or no longer needed, any remaining solution should be disposed of in a safe and responsible manner
Figure 6 displays the PRCC output with [GSH]/[GSSG] ratio at PN28 as outcome of interest for the control C3H mice and the RP rd1 mice
